Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.62 USD
−50.62 M USD
34.16 M USD
94.34 M
About OmniAb, Inc.
Sector
CEO
Matthew William Foehr
Website
Headquarters
Emeryville
Founded
2015
FIGI
BBG011J3QM39
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OABI is 3.92 USD — it has increased by 1.82% in the past 24 hours. Watch OmniAb, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange OmniAb, Inc. stocks are traded under the ticker OABI.
OABI stock has fallen by −4.62% compared to the previous week, the month change is a −1.01% fall, over the last year OmniAb, Inc. has showed a −12.89% decrease.
We've gathered analysts' opinions on OmniAb, Inc. future price: according to them, OABI price has a max estimate of 12.00 USD and a min estimate of 8.00 USD. Watch OABI chart and read a more detailed OmniAb, Inc. stock forecast: see what analysts think of OmniAb, Inc. and suggest that you do with its stocks.
OABI reached its all-time high on Oct 27, 2022 with the price of 10.50 USD, and its all-time low was 1.91 USD and was reached on Nov 7, 2022. View more price dynamics on OABI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OABI stock is 3.79% volatile and has beta coefficient of 1.26. Track OmniAb, Inc. stock price on the chart and check out the list of the most volatile stocks — is OmniAb, Inc. there?
Today OmniAb, Inc. has the market capitalization of 459.13 M, it has decreased by −0.77% over the last week.
Yes, you can track OmniAb, Inc. financials in yearly and quarterly reports right on TradingView.
OmniAb, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
OABI earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.14 USD resulting in a −16.36% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about OmniAb, Inc. earnings.
OmniAb, Inc. revenue for the last quarter amounts to 4.17 M USD, despite the estimated figure of 8.41 M USD. In the next quarter, revenue is expected to reach 10.61 M USD.
OABI net income for the last quarter is −16.37 M USD, while the quarter before that showed −13.63 M USD of net income which accounts for −20.12% change. Track more OmniAb, Inc. financial stats to get the full picture.
No, OABI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 106.00 employees. See our rating of the largest employees — is OmniAb, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OmniAb, Inc. EBITDA is −61.30 M USD, and current EBITDA margin is −145.57%. See more stats in OmniAb, Inc. financial statements.
Like other stocks, OABI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OmniAb, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OmniAb, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OmniAb, Inc. stock shows the sell signal. See more of OmniAb, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.